Found: 76
Select item for more details and to access through your institution.
Zr-mAb3481 PET for HER3 tumor status assessment during lapatinib treatment.
- Published in:
- mAbs, 2017, v. 9, n. 8, p. 1370, doi. 10.1080/19420862.2017.1371382
- By:
- Publication type:
- Article
ImmunoPET and biodistribution with human epidermal growth factor receptor 3 targeting antibody <sup>89</sup>Zr-RG7116.
- Published in:
- mAbs, 2014, v. 6, n. 4, p. 1051, doi. 10.4161/mabs.29097
- By:
- Publication type:
- Article
The Effect of Pregnancy and Inflammatory Bowel Disease on the Pharmacokinetics of Drugs Related to Inflammatory Bowel Disease—A Systematic Literature Review.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 6, p. 1241, doi. 10.3390/pharmaceutics14061241
- By:
- Publication type:
- Article
Modelling Tools to Characterize Acetaminophen Pharmacokinetics in the Pregnant Population.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 8, p. 1302, doi. 10.3390/pharmaceutics13081302
- By:
- Publication type:
- Article
<sup>89</sup>Zr-PET imaging to predict tumor uptake of <sup>177</sup>Lu-NNV003 anti-CD37 radioimmunotherapy in mouse models of B cell lymphoma.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-10139-6
- By:
- Publication type:
- Article
Radiolabeled Monoclonal Antibody Against Colony-Stimulating Factor 1 Receptor Specifically Distributes to the Spleen and Liver in Immunocompetent Mice.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.786191
- By:
- Publication type:
- Article
<sup>111</sup>In-Trastuzumab Scintigraphy in HER2-Positive Metastatic Breast Cancer Patients Remains Feasible during Trastuzumab Treatment.
- Published in:
- Molecular Imaging, 2014, v. 13, n. 5, p. 1, doi. 10.2310/7290.2014.00011
- By:
- Publication type:
- Article
Feasibility of Vascular Endothelial Growth Factor Imaging in Human Atherosclerotic Plaque Using <sup>89</sup>Zr-Bevacizumab Positron Emission Tomography.
- Published in:
- Molecular Imaging, 2013, v. 12, n. 4, p. 235, doi. 10.2310/7290.2012.00034
- By:
- Publication type:
- Article
Advances and challenges in immunoPET methodology.
- Published in:
- Frontiers in Nuclear Medicine, 2024, p. 01, doi. 10.3389/fnume.2024.1360710
- By:
- Publication type:
- Article
Advances and challenges in immunoPET methodology.
- Published in:
- Frontiers in Nuclear Medicine, 2024, p. 1, doi. 10.3389/fnume.2024.1360710
- By:
- Publication type:
- Article
Advances and challenges in immunoPET methodology.
- Published in:
- Frontiers in Nuclear Medicine, 2024, p. 1, doi. 10.3389/fnume.2024.1360710
- By:
- Publication type:
- Article
Advances and challenges in immunoPET methodology.
- Published in:
- Frontiers in Nuclear Medicine, 2024, p. 1, doi. 10.3389/fnume.2024.1360710
- By:
- Publication type:
- Article
Whole-Body HER2 Heterogeneity Identified on HER2 PET in HER2-Negative, -Low, and -Positive Metastatic Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 10, p. 1540, doi. 10.2967/jnumed.124.267636
- By:
- Publication type:
- Article
Long Versus Short Axial Field of View Immuno-PET/CT: Semiquantitative Evaluation for <sup>89</sup>Zr-Trastuzumab.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1815, doi. 10.2967/jnumed.123.265621
- By:
- Publication type:
- Article
<sup>89</sup>Zr-3,2-HOPO-Mesothelin Antibody PET Imaging Reflects Tumor Uptake of Mesothelin-Targeted <sup>227</sup>Th-Conjugate Therapy in Mice.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 11, p. 1715, doi. 10.2967/jnumed.121.263079
- By:
- Publication type:
- Article
<sup>89</sup>Zr-3,2-HOPO-mesothelin antibody PET imaging 1 reflects tumor uptake of mesothelin targeted <sup>227</sup>Th-conjugate therapy in mice.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.121.263079
- By:
- Publication type:
- Article
<sup>89</sup>Zr-3,2-HOPO-mesothelin antibody PET imaging reflects tumor uptake of mesothelin targeted <sup>227</sup>Th-conjugate therapy in mice.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.263079
- By:
- Publication type:
- Article
<sup>89</sup>Zr-3,2-HOPO-mesothelin antibody PET imaging reflects tumor uptake of mesothelin targeted <sup>227</sup>Th-conjugate therapy in mice.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.121.263079
- By:
- Publication type:
- Article
<sup>89</sup>Zr-3,2-HOPO-mesothelin antibody PET imaging 1 reflects tumor uptake of mesothelin targeted <sup>227</sup>Th-conjugate therapy in mice.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263079
- By:
- Publication type:
- Article
<sup>89</sup>Zr-3,2-HOPO-mesothelin antibody PET imaging reflects tumor uptake of mesothelin targeted <sup>227</sup>Th-conjugate therapy in mice.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 5, p. 1, doi. 10.2967/jnumed.121.263079
- By:
- Publication type:
- Article
Mesothelin/CD3 half-life extended bispecific T-cell engager molecule shows specific tumor uptake and distributes to mesothelin and CD3 expressing tissues.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.259036
- By:
- Publication type:
- Article
Mesothelin/CD3 half-life extended bispecific T-cell engager molecule shows specific tumor uptake and distributes to mesothelin and CD3 expressing tissues.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.259036
- By:
- Publication type:
- Article
Mesothelin/CD3 half-life extended bispecific T-cell engager molecule shows specific tumor uptake and distributes to mesothelin and CD3 expressing tissues.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.259036
- By:
- Publication type:
- Article
Mesothelin/CD3 half-life extended bispecific T-cell engager molecule shows specific tumor uptake and distributes to mesothelin and CD3 expressing tissues.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.259036
- By:
- Publication type:
- Article
Mesothelin/CD3 half-life extended bispecific T-cell engager molecule shows specific tumor uptake and distributes to mesothelin and CD3 expressing tissues.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.259036
- By:
- Publication type:
- Article
Mesothelin/CD3 half-life extended bispecific T-cell engager molecule shows specific tumor uptake and distributes to mesothelin and CD3 expressing tissues.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.120.259036
- By:
- Publication type:
- Article
Mesothelin/CD3 half-life extended bispecific T-cell engager molecule shows specific tumor uptake and distributes to mesothelin and CD3 expressing tissues.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.259036
- By:
- Publication type:
- Article
Biodistribution of a CD3/EpCAM bispecific T-cell engager is driven by the CD3 arm.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.241877
- By:
- Publication type:
- Article
Molecular imaging of PD-L1 expression and dynamics with the adnectin-based PET tracer <sup>18</sup>F BMS-986192.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.241364
- By:
- Publication type:
- Article
Development and evaluation of interleukin-2 derived radiotracers for PET imaging of Tcells in mice.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.238782
- By:
- Publication type:
- Article
Biodistribution of a CD3/EpCAM bispecific T-cell engager is driven by the CD3 arm.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.241877
- By:
- Publication type:
- Article
Development and evaluation of interleukin-2 derived radiotracers for PET imaging of T-cells in mice.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.238782
- By:
- Publication type:
- Article
Biodistribution of a CD3/EpCAM bispecific T-cell engager is driven by the CD3 arm.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.120.241877
- By:
- Publication type:
- Article
Molecular imaging of PD‐L1 expression and dynamics with the adnectin‐based PET tracer<sup> 18</sup>F‐ BMS‐986192.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.119.241364
- By:
- Publication type:
- Article
Development and evaluation of interleukin-2 derived radiotracers for PET imaging of Tcells in mice.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.119.238782
- By:
- Publication type:
- Article
Biodistribution of a CD3/EpCAM bispecific T-cell engager is driven by the CD3 arm.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.120.24187
- By:
- Publication type:
- Article
Molecular imaging of PD-L1 expression and dynamics with the adnectin-based PET tracer <sup>18</sup>F-BMS-986192.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.119.241364
- By:
- Publication type:
- Article
Development and evaluation of interleukin-2 derived radiotracers for PET imaging of Tcells in mice.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.119.238782
- By:
- Publication type:
- Article
Molecular imaging of PD-L1 expression and dynamics with the adnectin-based PET tracer <sup>18</sup>F-BMS-986192.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 8, p. 1, doi. 10.2967/jnumed.119.241364
- By:
- Publication type:
- Article
Development and evaluation of interleukin-2 derived radiotracers for PET imaging of Tcells in mice.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 8, p. 1, doi. 10.2967/jnumed.119.238782
- By:
- Publication type:
- Article
Biodistribution of a CD3/EpCAM bispecific T-cell engager is driven by the CD3 arm.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.120.241877
- By:
- Publication type:
- Article
Molecular imaging of PD-L1 expression and dynamics with the adnectin-based PET tracer <sup>18</sup>F-BMS-986192.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.119.241364
- By:
- Publication type:
- Article
Development and evaluation of interleukin-2 derived radiotracers for PET imaging of Tcells in mice.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.119.238782
- By:
- Publication type:
- Article
Biodistribution of a CD3/EpCAM bispecific T-cell engager is driven by the CD3 arm.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.120.241877
- By:
- Publication type:
- Article
Molecular imaging of PD‐L1 expression and dynamics with the adnectin‐based PET tracer <sup>18</sup>F‐BMS‐986192.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.119.241364
- By:
- Publication type:
- Article
Development and evaluation of interleukin-2 derived radiotracers for PET imaging of Tcells in mice.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.119.238782
- By:
- Publication type:
- Article
Biodistribution of a CD3/EpCAM bispecific T-cell engager is driven by the CD3 arm.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.120.241877
- By:
- Publication type:
- Article
Molecular imaging of PD-L1 expression and 1 dynamics with the adnectin-based PET tracer 18F BMS-986192.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.119.241364
- By:
- Publication type:
- Article
Development and evaluation of interleukin-2 derived radiotracers for PET imaging of Tcells in mice.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.119.238782
- By:
- Publication type:
- Article
Development and evaluation of interleukin-2 derived radiotracers for PET imaging of Tcells in mice.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 4, p. 1, doi. 10.2967/jnumed.119.238782
- By:
- Publication type:
- Article